Angiotensin type 2 receptor antagonism as a new target to manage gout-Reference-Cited by-同舟云学术

Angiotensin type 2 receptor antagonism as a new target to manage gout

Published:2022-09-29 Issue:6 Volume:30 Page:2399-2410
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Vieira Thiago Neves,Saraiva André L. Lopes,Guimarães Rafaela Mano,Luiz João Paulo Mesquita,Pinto Larissa Garcia,de Melo Rodrigues Ávila Veridiana,Goulart Luiz Ricardo,Cunha-Junior Jair Pereira,McNaughton Peter Anthony,Cunha Thiago Mattar,Ferreira Juliano,Silva Cassia Regina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-022-01076-x.pdf

Reference48 articles.

1. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276:39721–39726. https://doi.org/10.1074/jbc.M105253200

2. Alves-Filho JC, Snego F, Souto FO et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708–712. https://doi.org/10.1038/NM.2156

3. Busso N, So A (2010) Mechanisms of inflammation in gout. Arthritis Res Ther 12:1–8

4. Carey RM, Jin XH, Siragy HM (2001) Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens 14:98s–102s

5. Caspani O, Zurborg S, Labuz D, Heppenstall PA (2009) The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS ONE. https://doi.org/10.1371/journal.pone.0007383

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation;Current Opinion in Pharmacology;2023-12

2. New drug targets for the treatment of gout arthritis: what’s new?;Expert Opinion on Therapeutic Targets;2023-08-03

3. Characterization of the First Animal Toxin Acting as an Antagonist on AT1 Receptor;International Journal of Molecular Sciences;2023-01-24